Skip to main content
ENDO 2026 Main banner

Dolores M. Shoback, MD

UCSF/VA Medical Center
San Francisco, CA, United States

Dolores Shoback received her Bachelor’s Degree (Biology) from the University of Pennsylvania and graduated from Johns Hopkins University School of Medicine in 1977. She trained training in Internal Medicine at the Johns Hopkins Hospital on the Osler Medical Service before completing clinical and research fellowship in Endocrinology/Hypertension at Harvard Medical School in 1983. She joined the faculty of the University of California, San Francisco in 1985 in the Department of Medicine where she is currently Professor of Medicine and Staff Endocrinologist at the San Francisco VA Medical Center and Associate Director of the Diabetes, Endocrinology and Metabolism Fellowship Training Program at UCSF. She has research interests in the mechanisms underlying regulation of parathyroid hormone secretion with specific focus on the role of calcium-sensing receptors in parathyroid cells and osteoblasts. Her clinical activities and research interests focus on metabolic bone diseases, parathyroid disorders, and osteoporosis. She has participated in investigations into the role of calcium receptor activation in the control of parathyroid hormone hypersecretion in primary hyperparathyroidism and parathyroid carcinoma and in conducted clinical trials on parathyroid hormone in the treatment of osteoporosis and as replacement therapy in patients with hypoparathyroidism. She has co-authored over 180 papers, reviews and editorials. She served as Secretary-Treasurer of the Endocrine Society (2019-2022). She participated in the development of guidelines for the management of primary hyperparathyroidism (2008, 2013, 2016), the pharmacologic treatment of postmenopausal osteoporosis for the Endocrine Society (2013-20), the management of hypoparathyroidism in adults for the European Society of Endocrinology (2013-2015), the First International Workshop (2016) and the Second International Workshop on Hypoparathyroidism (2021-22) and has been appointed to the ASBMR Task Force on alignment of osteoporosis guidelines. She is a recipient of the Sidney Ingbar Award for Distinguished Service to the Endocrine Society (2016) and the Endocrine Society Scholarly Physician Award (2024).

Disclosure information not submitted.

Presentation(s):